This week, Boston Scientific agreed to pay $1B+ for stroke prevention device firm Silk Road Medical; the FDA asked for feedback on patient safety for non-device medical software; and a former medtech CEO was sentenced to six years for her part in a phony device scheme.

A new report from Informa's Meddevicetracker outlines the market drivers and competitive landscape for the carotid artery stents and embolic protection devices market.

The company will focus on developing its VenoValve system to treat chronic venous insufficiency and a second product for venous disease.

The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the second day of the meeting.